David A Cretella
Overview
Explore the profile of David A Cretella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsai Y, Bookstaver P, Kohn J, Justo J, Childress D, Stramel S, et al.
Antimicrob Steward Healthc Epidemiol
. 2024 Mar;
4(1):e35.
PMID: 38500714
Objective: To evaluate temporal trends in the prevalence of gram-negative bacteria (GNB) with difficult-to-treat resistance (DTR) in the southeastern United States. Secondary objective was to examine the use of novel...
2.
Stover K, Hawkins B, Keck J, Barber K, Cretella D
Drugs Context
. 2023 Nov;
12.
PMID: 38021410
Invasive fungal infections are a strong contributor to healthcare costs, morbidity and mortality, especially amongst hospitalized patients. Historically, was responsible for approximately 15% of all nosocomial bloodstream infections. In the...
3.
Roper S, Wingler M, Cretella D
Pharmacy (Basel)
. 2023 Jun;
11(3).
PMID: 37368430
(1) Background: Antibiotics are received by a majority of adult intensive care unit (ICU) patients. Guidelines recommend antibiotic de-escalation (ADE) when culture results are available; however, there is less guidance...
4.
Puzz L, Plauche E, Cretella D, Harrison V, Wingler M
Antibiotics (Basel)
. 2023 Apr;
12(4).
PMID: 37107141
(1) Background: Pneumonia is the leading diagnosis associated with antibiotic use in hospitalized children. The Infectious Diseases Society of America published pediatric community-acquired pneumonia (CAP) guidelines in 2011, but adherence...
5.
Vance M, Cretella D, Ward L, Vijayvargiya P, Esquer Garrigos Z, Wingler M
Pharmacy (Basel)
. 2023 Apr;
11(2).
PMID: 37104080
(1) Background: Risk factors for extended-spectrum beta-lactamase (ESBL) infections could vary geographically. The purpose of this study was to identify local risk factors for ESBL production in patients with Gram-negative...
6.
Keck J, Cretella D, Stover K, Wagner J, Barber K, Jhaveri T, et al.
Antibiotics (Basel)
. 2023 Feb;
12(2).
PMID: 36830104
Delays in the treatment of proven invasive fungal disease have been shown to be harmful. However, empiric treatment for all patients at risk of infection has not demonstrated benefit. This...
7.
Keck J, Wingler M, Cretella D, Vijayvargiya P, Wagner J, Barber K, et al.
Ther Adv Infect Dis
. 2022 Dec;
9:20499361221138346.
PMID: 36451936
Febrile neutropenia (FN) is associated with mortality rates as high as 40%, highlighting the importance of appropriate clinical management in this patient population. The morbidity and mortality of FN can...
8.
Markovich K, Wingler M, Stover K, Barber K, Wagner J, Cretella D
Diseases
. 2022 Nov;
10(4).
PMID: 36412604
The purpose of this study was to assess the clinical impact of the BioFire FilmArray Meningitis/Encephalitis (ME) panel on antimicrobial use and clinical outcomes. This retrospective, quasi-experiment evaluated adult and...
9.
Wingler M, Cretella D, Wagner J, Barber K, Bookstaver P, Jones B, et al.
J Am Pharm Assoc (2003)
. 2022 Sep;
62(6):1756-1760.
PMID: 36115761
Pharmacy residency recruitment and interviews have been significantly impacted by the COVID-19 pandemic. Many traditional recruitment events and interviews were transitioned from in-person to virtual, and new approaches to recruitment,...
10.
Wingler M, Cretella D, Wagner J, Barber K, Bookstaver P, Freeman L, et al.
J Am Coll Clin Pharm
. 2022 Aug;
PMID: 35942359
Introduction: Due to the COVID-19 pandemic, most pharmacy residency programs changed to an all-virtual format for recruitment and interviews for the 2020-2021 application cycle. There are no data evaluating the...